Chartwell Investment Partners, LLC Scholar Rock Holding Corp Transaction History

Chartwell Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$11.89 - $24.68 $198,919 - $412,896	-16,730 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$24.14 - $35.18 $7,724 - $11,257	-320 Reduced 1.88%	16,730 $415,000
Q2 2021 Jul 19, 2021	BUY	$26.34 - $46.62 $4,056 - $7,179	154 Added 0.91%	17,050 $492,000
Q1 2021 May 03, 2021	SELL	$45.96 - $68.02 $41,731 - $61,762	-908 Reduced 5.1%	16,896 $856,000
Q4 2020 Feb 09, 2021	BUY	$13.72 - $51.57 $244,270 - $918,152	17,804 New	17,804 $864,000

247

89.8M

706K

456K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $1.56B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.